Author

Edwige Baudry

Observed names: E Baudry, E. Baudry

Institution: Institut de Cancérologie de Lorraine

Observed institutions: Université Paris-Saclay, Institut Gustave Roussy, Institut de Cancérologie de Lorraine, Hôpital René Huguenin, Pitié-Salpêtrière Hospital, Hôpital Charles-Foix, Bicêtre Hospital, Université Pierre-et-Marie-Curie, Institut Curie, Université de Lorraine

ORCID: 0009-0008-2583-7153

Observed ORCID: 0009-0008-2583-7153

OpenAlex ID: A5074336193

Cyclophosphamide dose adjustment based on body weight and albuminemia in elderly patients treated with R-mini-CHOP

2019 · E. Baudry, S. Huguet, et al. · Cancer Chemotherapy and Pharmacology · 12

Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study

2023 · Edwige Baudry, Natacha Naoun, et al. · European Journal of Cancer · 4

Real-world treatment sequences and overall survival in metastatic bladder cancer: The STATES-Bladder study

2026 · Fabien Moinard-Butot, Jean-Baptiste Barbe-Richaud, et al. · Urologic Oncology Seminars and Original Investigations · 2

Spondylodiscite à Mycobacterium tuberculosis et Streptococcus agalactiae

2014 · L. Goehrs, E. Baudry, et al. · Médecine et Maladies Infectieuses · 2

Treatment sequence (TS) and overall survival (OS) in patients with metastatic urothelial cancer (mUC): An observational, multicenter, real-life STATES-Bladder study.

2025 · Fabien Moinard-Butot, Jean-Baptiste Barbe-Richaud, et al. · Journal of Clinical Oncology

Abstract 31: A population pharmacokinetic-pharmacodynamic (POP-PK/PD) modelling of EZN-3042 administered with or without docetaxel in patients with advanced solid tumors or lymphoma.

2013 · E Baudry, Keyvan Rezai, et al. · Cancer Research

Pharmacologie et personnes âgées

2012 · F. Piette, E. Baudry, et al. · Références en réanimation

Works count: 7

Citation count: 20

H-index: 2

I10-index: 1